ICA Group Wealth Management’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding RCEL
SCM
ICA Group Wealth Management's RCEL Position: Q2 2024 in Review
ICA Group Wealth Management sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 500 shares — an estimated $8.02K sold.
ICA Group Wealth Management first reported a position in RCEL in Q4 2022 and held it in 5 quarters. The position peaked at $30.6K in Q2 2023. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.
- ICA Group Wealth Management reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
- ICA Group Wealth Management sold 500 Avita Medical shares in Q2 2024, an estimated $8.02K.
- ICA Group Wealth Management first reported a position in Avita Medical in Q4 2022 and held it in 5 quarters.
- ICA Group Wealth Management's Avita Medical position peaked at $30.6K in Q2 2023.
- 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.
Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.